
Manon Boisclair Ms Icdd Cbc
• Understand the startup journey of pre-IPO companies and transitions needed to successfully scale up • Identifying promising research... | Canada
*50 free lookup(s) per month.
No credit card required.
Manon Boisclair Ms Icdd Cbc’s Emails mb****@in****.com
Manon Boisclair Ms Icdd Cbc’s Phone Numbers No phone number available.
Social Media
Manon Boisclair Ms Icdd Cbc’s Location Canada
Manon Boisclair Ms Icdd Cbc’s Expertise • Understand the startup journey of pre-IPO companies and transitions needed to successfully scale up • Identifying promising research by leading academic and biotech partners to create new companies of scale and by providing expertise, infrastructure, and capital to help existing companies scale up • Involved in private equity, seasoned angel investor with a solid track record in business development, governance, and Series A & B fundraising • Certified corporate board director from Harvard Business School, Institute of Corporate Directors and Competent Boards in ESG/Sustainability • Serving on Boards of VC-backed companies as well as nonprofit organizations • Advisor to VC firms in life science and ESG/sustainability • Active in the high growth startup/scale up ecosystem, mentor to entrepreneurs affiliated with Creative Destruction Lab (CDL) • Founder of InnovID B2 LLC., a boutique consultancy firm for life science companies. • 20+ years of international executive management roles with NASDAQ-listed BioPharma companies (Merck, Novartis, Celgene and Intercept) in the US, Canada and Europe. • Extensive global operations and go-to-market medical/marketing strategy experience having worked on several blockbusters as well as early pipeline compounds across therapeutic areas Areas of expertise include: - C-Suite - Startup - Leadership - Business Development - Fundraising & revenue generation - Impact Advisory - M&A, exits - Strategic Partnerships - Private Equity (angel and VC investing) - Governance - Commercialization & Go-to-Market - International scaling - Change management - Product Launch - Medical/Marketing - Digital Innovation - ESG & Sustainability Citizenships: American & Canadian
Manon Boisclair Ms Icdd Cbc’s Current Industry Linda
Manon
Boisclair Ms Icdd Cbc’s Prior Industry
Novartis
|
Celgene
|
Intercept Pharmaceuticals
|
Anges Quebec
|
Medhelper
|
Innovid B2
|
Ovensa
|
Mcgill University Desautels Faculty Of Management
|
Nursesimple
|
Syantra
|
Accelia Capital
|
Gray Oncology Solutions
|
Neuro Solutions
|
Linearis
|
Linda
Not the Manon Boisclair Ms Icdd Cbc you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Linda
Strategic Advisor
Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Linearis
Ventures (General Partner) / Labs (COO & CCO)
Wed Feb 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Neuro Solutions
Strategic Advisor
Fri Apr 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Accelia Capital
Limited Partner & Investment Committee Advisor
Wed Dec 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Gray Oncology Solutions
Board of Directors (Lead Director)
Wed Dec 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Nursesimple
Board of Directors (Independent Member)
Fri Jan 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Sep 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Syantra
Chief Commercial Officer
Fri Jan 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Mcgill University Desautels Faculty Of Management
Guest Panelist
Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Ovensa
Board of Directors
Wed Jan 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Innovid B2
Impact Strategic Consulting (President, Founder)
Thu Aug 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Medhelper
Board of Directors
Mon Jul 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Anges Quebec
Angel Investor & Investment Selection Advisor
Mon Apr 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Intercept Pharmaceuticals
Head Global Medical Affairs (NASH & Liver Rare Diseases)
Thu Mar 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Aug 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Celgene
Head Global Scientific Operations
Sat Nov 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Mar 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Celgene
Head Global Scientific Communications (Multiple Myeloma Franchise)
Sun Jan 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Nov 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Novartis
Global Director Medical Affairs (Solid Tumors & Rare Oncology Diseases)
Sun Apr 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Dec 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)